NR4A2 and early-onset autosomal dominant Alzheimer disease: In particular, NR4A2 has been implicated in Alzheimer’s disease (AD) progression, Parkinson disease, schizophrenia, substance abuse (alcohol and cocaine), neurodevelopmental disorders and cognitive impairment among others [7,13,14,15,16,17,18].